Medindia

X

Orchid gets FDA Approval for Cefotaxime Injections

by Medindia Content Team on  August 16, 2006 at 7:54 PM Drug News   - G J E 4
Orchid gets FDA Approval for Cefotaxime Injections
Orchid Chemicals & Pharmaceuticals, a leading player in the Indian drug industry, has received a formal approval from the US Food and Drug Authority (FDA) for three of its abbreviated new drug applications (ANDAs) for Cefotaxime.
Advertisement

Orchid will be launching this product in the US through its exclusive distribution partner, Apotex, the Chennai-based company said in a release Wednesday.

Advertisement
The FDA approvals for Cefotaxime ANDAs mark another milestone in Orchid's efforts to offer a full-line injectable product range in the US generic market, it said.

Though a mature off-patent product, Cefotaxime has limited competition and Orchid expects a notable market share and revenue stream from it.

Orchid has filed 31 ANDAs with the FDA and 15 of them have been approved so far.

(Source: IANS)
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All